Skip to main content

Handelsbanken Fonder AB

Position in NBIX — Neurocrine Biosciences Inc

CIK 1398318 STOCKHOLM, V7

Position in NBIX

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$34,697,498
+$9,947,900 QoQ
Shares Held
205,871
+9.6% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3
of 76 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $87,470,140 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (39.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
205,871 $34,697,498

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,697,498 205,871
2026-03-31 $24,749,598 187,867
2025-12-31 $28,488,966 200,867
2025-09-30 $15,366,977 109,467
2025-06-30 $13,067,612 103,967
2025-03-31 $9,519,010 86,067
2024-12-31 $3,667,345 26,867
2024-09-30 $3,095,615 26,867
2024-06-30 $3,065,497 22,267
2024-03-31 $3,181,400 23,067
2023-12-31 $2,485,915 18,867
2023-09-30 $1,953,787 17,367
2023-06-30 $1,637,708 17,367
2023-03-31 $1,778,131 17,567
2022-12-31 $1,572,666 13,167
2022-09-30 $1,621,508 15,267
2022-06-30 $1,488,227 15,267
2022-03-31 $1,431,281 15,267
2021-12-31 $865,923 10,167
2021-09-30 $1,675,259 17,467
2021-06-30 $1,699,888 17,467
2021-03-31 $1,757,015 18,067
2020-12-31 $1,731,721 18,067
2020-09-30 $21,152,026 219,967
2020-06-30 $24,395,974 199,967
2020-03-31 $17,656,200 204,000